Irene Ghobrial, MD talks about genomic aberrationsDec 19, 20171 min readIn this video at ASH 2017, Irene Ghobrial, MD describes the research and recent discoveries that have been possible thanks to PCROWD samples.
News from the PANGEA study at Dana-Farber Cancer Institute: Which Smoldering Myeloma (SMM) Patients Are More Likely to Progress? Inside the PANGEA-SMM Model.The PANGEA Model is a tool that helps patients predict their personal risk of developing myeloma within the next 1 to 10 years ( The Pangea Model - SMM Risk Calculator ). The model incorporates both
Comments